baber/WOPTO huggingface dataset:
Patent JP-2512796-B2 (JP)
IPC: A61K38/095
Filed: 1988-06-24
Granted: 1996-07-03
Abstract: The invention is directed to a method of treating a T cell-mediated autoimmune disease in animals, including humans, by the oral or enteral administration of autoantigens, fragments of autoantigens, or analogs structurally related to those autoantigens, which are specific for the particular autoimmune disease The method of the invention includes both prophylactic and therapeutic measures.
Patent JP-4128633-B2 (JP)
IPC: C07D257/04
Filed: 1998-06-29
Granted: 2008-07-30
Abstract: A process of direct metalation of phenyltetrazoles useful for preparing compounds of formula (II) intermediates for the synthesis of angiotensin II antagonists is described.
Patent JP-2794299-B2 (JP)
IPC: C01F17/30
Filed: 1988-09-29
Granted: 1998-09-03
Abstract: Disclosed is a process for the preparation of multi-element metal oxide, high temperature superconductor precursor powder comprising spraying a homogenous solution of a multi-element metal salt solution mixed in a stoichiometric ratio corresponding to the desired superconducting composition into a horizontal tube-like furnace being heated to a temperature of 800 DEG -1000 DEG  C., transporting resulting sprayed mist along the main axis of the furnace tube by the aid of hot air and collecting resultant finely divided metal oxide powder by the aid of a filter, whereby the resultant mixed metal oxide powder is a precursor for the preparation of a high temperature superconducting ceramic.
Patent JP-2902113-B2 (JP)
IPC: A61K31/40
Filed: 1992-11-06
Granted: 1999-06-07
Abstract: A fomentation containing ketorolac, one of nonsteroidal anti-inflammatory analgesics, or a salt thereof as an active ingredient, a water-soluble high-molecular compound as a base ingredient, a humectant, water, and optionally an absorption promoter. <IMAGE>
Patent JP-H0753166-B2 (JP)
IPC: A61F2/24
Filed: 1988-11-14
Abstract: PCT No. PCT/FR88/00558 Sec. 371 Date Jul. 12, 1990 Sec. 102(e) Date Jul. 12, 1990 PCT Filed Nov. 14, 1988 PCT Pub. No. WO89/04154 PCT Pub. Date May 18, 1989.An artificial cardiac valve made of biocompatible material comprises an annular valve body and a flap pivotally lodged inside the valve body and possessing linking elements for cooperating with guiding and restraining means provided on an internal side wall of the annular valve body. The flap consists of a disc folded along an axis XX' parallel to one of its diameters through an angle between 0 and 30 degrees in such a way that opening of the valve is effected in two consecutive phases. The first phase corresponds to a rotation of the flap about the contact and hinging point A between a rear part of the flap and a lower edge of the side wall of the valve body until said linking elements abut against the guiding and restraining means. The second phase corresponds to a rotation of about an axis ZZ'  parallel to the axis XX' until the rear part of the flap is parallel to the axis YY' of the annular body.
Patent JP-3258326-B2 (JP)
IPC: D04H1/42
Filed: 1993-09-30
Granted: 2002-02-18
Abstract: A lactide polymer coating resulting in a strong, repulpable, high gloss, paper coating. The lactide polymer comprises a plurality of poly(lactide) polymer chains, residual lactide in concentration of less than about 5 percent and water in concentration of less than about 2000 parts-per-million. A process for coating paper with the lactide polymer composition is also disclosed.
Patent JP-2621123-B2 (JP)
IPC: C12Q1/68
Filed: 1992-12-09
Granted: 1997-06-18
Abstract: 2'-Deoxyisoguanosine, isosteric analogues and isoguanosine derivatives of formulae I-V, processes for their production via compounds of the general formulae a or b and reaction with aroyl isocyanates or from compounds of the general formulae VI-IX by photochemical irradiation. A further production process is the conversion of deoxyguanosines or guanosines by means of persilylation, reaction with ammonia and deamination in the 2 position. The compounds are suitable as pharmaceutical agents with antiviral efficacy.
Patent JP-3293834-B2 (JP)
IPC: C12N15/12
Filed: 1997-10-03
Granted: 2002-06-17
Abstract: A method of determining the gender of a bird in ovo comprises detecting the presence or absence of an elevated level of a sex-related hormone in the extra-embryonic fluid of the bird egg, and then determining the gender of the bird within the egg from the presence of an elevated level of a sex-related hormone therein. In particular embodiments, the sex-related hormone is an estrogen. In other representative embodiments, the invention provides methods in which the extra-embryonic fluid is allantoic fluid. In other illustrative embodiments, the method can be carried out on chicken eggs prior to or during transfer of the eggs from incubator to hatcher.
Patent JP-3809848-B2 (JP)
IPC: A61B19/00
Filed: 1994-03-07
Granted: 2006-08-16
Abstract: A method of treating tissue damage comprises applying a negative pressure to a wound sufficient in time and magnitude to promote tissue migration and thus facilitate closure of the wound. The method is applicable to wounds, burns, infected wounds, and live tissue attachments. A wound treatment apparatus is provided in which a fluid impermeable wound cover is sealed over a wound site. A screen in the form of an open-cell foam screen or a rigid porous screen is placed beneath the wound cover over the wound. A vacuum pump supplies suction within the wound cover over the treatment site.
Patent JP-3001979-B2 (JP)
IPC: A61P21/02
Filed: 1996-01-03
Granted: 2000-01-24
Abstract: The invention is concerned with hydroxymethyl-imidazodiazepines and their esters of general formula I. These compounds can be used as anxiolytic and/or anticonvulsant and/or muscle relaxant and/or sedative-hypnotic active substances.
Patent JP-3672565-B2 (JP)
IPC: H04R1/00
Filed: 1995-02-28
Granted: 2005-07-20
Abstract: An ultrasonic transducer includes a transducer element having a backing element bonded thereto. The thickness of the backing element is selected to be less than or equal to half the length of an ultrasonic pulse, expressed in wavelengths of the center frequency of the pulse, so that the first reflection from the back side of the backing element is received by the transducer element before the primary pulse rings down. A method for mounting the transducer that reduces the formation of air bubbles includes the steps of forming a peaked mound and continually lowering the transducer to flatten the mound against the underside of the transducer.
Patent JP-3918021-B2 (JP)
IPC: G01K15/00
Filed: 1997-11-28
Granted: 2007-05-23
Abstract: A radiometer calibrating system utilizes an adjustable noise source for calibrating a radiometer. The noise source includes a transistor configured as a noise equivalent circuit having a gate port, drain port and source port. A source inductance providing series feedback for the noise source has one end coupled to the source port of the noise equivalent circuit and another end connected to the ground. A bias circuit controls the amount of DC bias applied to the noise equivalent circuit. In order to match the impedances in the noise source, an output impedance matching network in connected to the drain port and an input impedance matching network is connected to the gate port of the noise equivalent circuit. The output and input impedance networks have an output port and input port, respectively. Included in the noise source is a port switch that terminates a matched load to the output port when a cold thermal radiation temperature is generated at the input port, and alternatively, the port switch terminates the matched load to the input port when the warm thermal radiation temperature is generated at the output port.
Patent JP-3953102-B2 (JP)
IPC: C07K14/755
Filed: 1996-03-29
Granted: 2007-08-08
Abstract: PCT No. PCT/SE96/00419 Sec. 371 Date Nov. 26, 1997 Sec. 102(e) Date Nov. 26, 1997 PCT Filed Mar. 9, 1996 PCT Pub. No. WO96/30041 PCT Pub. Date Oct. 3, 1996A final drug product comprises a plasma protein selected from the group consisting of coagulation factor VIII and factor IX, in an aqueous solution. The concentration of oxygen in the solution is reduced and/or the solution contains an antioxidant. The solution further contains a carbohydrate in a concentration of at least 350 mg/ml. The protein activity after storage for at least 6 months at a temperature of from 0 DEG  C. to 40 DEG  C. is from 70% to 130% of its initial value. In a process for preparing the final drug product and a method for improving the long-term stability of coagulation factor VIII or factor IX in an aqueous solution, a carbohydrate is included in the solution in a concentration of at least 350 mg/ml and the solution is stored in its final container under an oxygen-reduced atmosphere or includes an antioxidant.
Patent JP-3565867-B2 (JP)
IPC: H01M8/24
Filed: 1998-03-31
Granted: 2004-09-15
Abstract: A gas impervious bi-polar separator plate for a proton exchange membrane fuel cell having at least one electronically conductive material in an amount in a range of about 50% to about 95% by weight of the separator plate, at least one resin in an amount of at least about 5% by weight of the separator plate, and at least one hydrophilic agent, where the electronically conductive material, the resin, and the hydrophilic agent are substantially uniformly dispersed throughout the separator plate.
Patent JP-3339640-B2 (JP)
IPC: C04B41/89
Filed: 1999-05-27
Granted: 2002-10-28
Abstract: Sanitary wares having a controlled surface are disclosed which are less likely to be stained or soiled and/or possess excellent gloss. The first sanitary ware comprises a sanitary ware body and a surface glaze layer provided on the sanitary ware body, wherein the surface glaze layer has a center line average roughness Ra of less than 0.07 µm. This sanitary ware is advantageous in that stains or soils are much less likely to be adhered to the surface thereof and, even when adhered to the surface thereof, can be removed by a weak water stream. The second sanitary ware comprises a sanitary ware body and a surface glaze layer provided on the sanitary ware body, wherein the surface glaze layer has a kurtosis Rku of less than 2.70. This sanitary ware advantageously possesses excellent surface gloss. The third sanitary ware comprises a sanitary ware body and a surface glaze layer provided on the sanitary ware body, wherein the surface of the surface glaze layer consists essentially of a vitreous component and is free from silica particles having a particle diameter of not less than 10 µm. This sanitary ware is advantageous in that stains or soils are less likely to be adhered to the surface thereof.
Patent ES-2337435-B2 (ES)
Title: Compuestos potenciadores de la actividad de glicosidasas mutantes.
Inventor: GARCIA MORENO MA ISABEL
IPC: A61K31/4355
Filed: 2008-10-22
Granted: 2011-01-25
Abstract: Compuestos potenciadores de la actividad de
glicosidasas mutantes, con actividad inhibidoras de enzimas
glicosidasas y también se refiere a un procedimiento para la
activación de \beta-glucosidasa mutante
(\beta-glucocerebrosidasa) y
\beta-galactosidasa mutante en pacientes que
padecen trastornos de almacenamiento lisosómico mediante la
administración de dichos compuestos inhibidores competitivos de las
enzimas, caracterizados por una especificidad de unión muy alta y
una relación favorable entre su concentración para actividad de
chaperona farmacológica y su concentración para actividad
inhibidora.
Patent ES-2424419-B2 (ES)
Title: Sistema en mar abierto para generar energía renovable
Inventor: PODDEY ALEXANDER
IPC: F03D9/00
Filed: 2012-04-04
Granted: 2015-04-01
Abstract: La presente invención se refiere a un sistema (1) en mar abierto para generar energía renovable, que comprende una disposición de transformadores (2) eléctricos de energía hidráulica, una disposición de instalaciones (3) de energía eólica, una disposición de elementos auxiliares que actúan hidrodinámicamente, estando previstos los elementos auxiliares que actúan hidrodinámicamente para influir en las olas marinas y/o las corrientes marinas con respecto a su energía en las posiciones de los transformadores (2) eléctricos de energía hidráulica y/o de las instalaciones (3) de energía eólica de manera dirigida, en particular por interferencia.
Patent IE-S86175-B2 (IE)
Title: A cill
Inventor: GOREY GERARD
IPC: E06B1/00
Filed: 2012-09-24
Abstract: The present invention relates to a cill replacement unit for retrofit works that is integrated as part of an external wall insulation system before a weather-proofing render is applied to the external wall insulation system. The present invention is also directed to a method of installing a cill replacement unit to form part of an external wall insulation system on an existing building, the external wall insulation system comprising a plurality of insulation sheets,and, the method comprising the steps of fixing the plurality of insulation sheets to an external wall of the building; and, adhering the cill replacement unit to at least one of the plurality of insulation sheets before any render application process has been carried out on the insulation sheets of the external wall insulation system. <Figure 4>
Patent AU-2001241999-B2 (AU)
Title: Process for organic acid bioleaching of nickel ore
Inventor: LIU HOUYUAN
IPC: C22B3/16
Filed: 2001-03-06
Granted: 2005-05-26
Abstract: A process for leaching an ore that contains nickel and magnesium includes mixing a microorganism that is capable of producing an organic acid, a nutrient, and an ore that contains nickel and magnesium for a period of time to dissolve the nickel and form a solution containing a nickel salt and a magnesium salt, separating the nickel from the magnesium in the salt solution.
Patent AU-2001261581-B2 (AU)
Title: Delivery devices for treatment of vascular disease
Inventor: NARAYANAN PALLASSANA V
IPC: A61F2/915
Filed: 2001-05-14
Granted: 2005-06-16
Abstract: An intralumen medical device comprising anti-proliferative and anti-thrombotic or anti-coagulant drugs, agents or compounds may be utilized in the treatment of vascular disease. The intralumen medical device is selectively coated with the drugs, agents or compounds for local delivery, thereby increasing their effectiveness and reducing potential toxicity associated with systemic use. The selective coating is utilized to ensure that the specific drugs, agents or compounds come into contact with or are delivered to the appropriate tissues and/or fluids for maximum effectiveness.
Patent AU-2002258677-B2 (AU)
Title: Bayerite alumina coated zeolite and cracking catalysts containing same
Inventor: ZHAO XINJIN
IPC: B01J37/03
Filed: 2002-03-28
Granted: 2007-03-22
Abstract: A catalyst suitable for use in fluid catalytic cracking of petroleum feedstock in the form of particulate of crystalline zeolite having a coating on it6s surface comprising bayerite phase alumina.
Patent AU-2002302536-B2 (AU)
Title: Non-combustible polyesterpolyol and/or polyetherpolyol preblend for producing foamed products
Inventor: RECKE DIERK-INGOLF
IPC: C08J9/00
Filed: 2002-04-16
Granted: 2008-03-06
Abstract: A non-flammable premix (I) for the production of foam products comprising polyetherpolyol and/or polyesterpolyol, additives such as catalyst, stabilizer, other additives and propellant contains 4-35 wt.% of a binary propellant mixture and 10-20 wt.% of a phosphorous compound.
Patent AU-2003240260-B2 (AU)
Title: Method and reagent system having a non-regenerative enzyme-coenzyme complex
Inventor: HOENES JOACHIM
IPC: C12Q1/00
Filed: 2003-05-16
Granted: 2008-05-22
Abstract: A method for producing a polymer layer on a transparent support. A photopolymerizable liquid composition is applied to the support. The photopolymerizable liquid composition is irradiated through the support such that polymerization of the liquid composition starts at the surface of the support and ends at a predetermined distance over the surface of the support. Only partial polymerization of the liquid composition takes place. A polymer layer with a predetermined thickness is formed on the support wherein the predetermined thickness is less than the thickness of the photopolymerizable liquid composition. The remaining photopolymerizable liquid composition is removed from the entire polymer layer.
Patent AU-2003244647-B2 (AU)
Title: Pharmaceutical preparation containing a benzimidazole compound mixed with microcrystalline cellulose and a method for its preparation
Inventor: MUSKULUS FRANK
IPC: A61K31/4439
Filed: 2003-07-16
Granted: 2008-04-17
Abstract: The present invention relates to oral pharmaceutical preparations in the form of pellets in which a benzimidazole compound is stabilized by combining it with microcrystalline cellulose.
Patent AU-2003295083-B2 (AU)
Title: Audio distribution system
Inventor: FOSTER ANDREW WILLIAM
IPC: H04R27/00
Filed: 2003-11-27
Granted: 2009-01-08
Abstract: An audio distribution system comprises a plurality of individual signal conditioning circuits connected in series. Each circuit comprises a signal conditioning unit to which an audio input (13) is fed. The output from the unit is fed to a precision signal addition device. Each circuit also comprises a balanced line level input (11), which is fed to a balanced to unbalanced precision signal converter the output of which is connected to the precision signal addition device. The output from the precision signal addition device is fed to an unbalanced to balanced converter which provides at its output a balanced line level signal (12). As compared with a conventional distribution system, the system enables only one balanced line level input to amplification equipment eliminating any mixing or control means that equipment and obtaining the need for a conventional mixer.
Patent AU-2003299411-B2 (AU)
Title: Device for stirring a liquid and injecting a gas into said liquid with limited clogging
Inventor: XUEREB CATHERINE
IPC: B01F27/91
Filed: 2003-12-04
Granted: 2009-01-29
Abstract: The surface of a lower disk of a turbine is lower than the surface of an upper disk. The lower disk has a smaller diameter than the upper disk and a diameter which is greater than or equal to the diameter of an annular space. A device for agitating a liquid in a reactor and injection of a gas into a liquid has a driving device above a receiver, with a vertical output axle with at least one movable device with axis flow immersed in the liquid, and a self-drawing turbine immersed in the reactor which can be driven by the output shaft. The output shaft is enclosed by a coaxial cylinder the lower end of which opens in the turbine and the upper end of which is connected in a sealed manner to the driving device. The cylinder is pierced with a hole for injecting gas in an annular space between the shaft and the cylinder. The turbine is made of two superimposed disks and an assembly of radial blades placed between the disks and fixed to them. The upper disk is pierced with a central hole into which fits the bottom end of the cylinder to describe an annular space between the cylinder and the edge of the hole by which liquid is drawn into the turbine. The gas-liquid dispersion expelled radially by the turbine is directed towards the axial flow device. The lower disk is at least partly hollow in the form of a ring. The axial flow moving device is a helix. An annular casing forms a deflector to send the gas- liquid dispersion ejected radially by the turbine to the axial flow moving device, pierced with two opposing central holes coaxial with the shaft. No additional agitator is placed on the output shaft below the axial flow device.
Patent AU-2004200540-B2 (AU)
Title: A bag system comprising a means of associating sampling receptacles
Inventor: THIERRY VERPOORT
IPC: A61M1/02
Filed: 2004-02-11
Granted: 2011-09-22
Abstract: The invention concerns a bag system (1) for taking a biological fluid, in particular blood, the said system comprising a device for taking the fluid which is in fluid communication with at least one fluid collecting bag (2), and a device for 5 sampling the fluid to be collected which comprises at least one sampling receptacle (15), the said sampling device comprising a means (10) of transferring the fluid from the bag system (1) into the sampling receptacle or receptacles (15), in which the transfer means (10) is provided with a means of associating the receptacle or receptacles (15), the said means being arranged to allow the 10 supporting of the receptacle or receptacles (15) in a standby position, the guidance of the receptacle or receptacles (15) to a transfer position and, after transfer, the dissociation of the receptacle or receptacles (15) from the bag system (1). Figure la. 131 22 8 19 FIG.la 15 35 13 6 25 9 a.35 3501 2 353 a 24 24c FIG lb
Patent AU-2004252589-B2 (AU)
Title: Low-viscous, radiation curable formulation, particularly for the stereolithographical production of earpieces
Inventor: KUTSCHINSKI MICHAEL
IPC: B29C67/00
Filed: 2004-06-17
Granted: 2007-03-22
Abstract: The invention relates to a biocompatible, low-viscous, radiation curable formulation, particularly for use in stereolithography, for use in medical technology, in particular, for producing earpieces, containing: a) 55-95% by weight of a monomeric or oligomeric dimethacrylate based on bisphenol A or bisphenol F; b) 0-20% by weight of a urethane methacrylate having a functionality of n<4 and a viscosity<15 Pa s; c) 2-15% by weight of a monomeric aliphatic or cycloaliphatic dimethacrylate having a viscosity<5 Pa s; d) 0-15% by weight of a monofunctional methacrylate having a viscosity<3 Pa s; e) 0.5-6% by weight of a photoinitiator or a combination of a number of photoinitiators whose absorption is located within the wavelength range of the laser beam used; f) 0.0001-2% by weight of the inhibitor 2,2,6,6-tetramethylpiperidin-1-yloxy (free radical), also in conjunction with known inhibitors; g) 0-40% by weight of fillers; h) 0-5% by weight of coloring pigments; i) 0-5% by weight of remaining additives such as UV stabilizers or spreading additives, whereby the proportions of constituents a) to h) total 100% by weight.
Patent AU-2004257696-B2 (AU)
Title: Use of parthenolide derivatives as antileukemic and cytotoxic agents
Inventor: JORDAN CRAIG T
IPC: A61K31/452
Filed: 2004-07-09
Granted: 2010-09-16
Abstract: Compounds of the formula having anti-tumor activity, wherein R<SUB>1 </SUB>and R<SUB>2 </SUB>are as described herein
Patent AU-2004267251-B2 (AU)
Title: Process for synthesising hydrocarbons
Inventor: STEYNBERG ANDRE PETER
IPC: C10G2/00
Filed: 2004-08-20
Granted: 2009-05-28
Abstract: A process ( 10 ) for synthesising hydrocarbons includes feeding a gaseous feedstock ( 18 ) comprising hydrogen and carbon monoxide, into a first Fischer-Tropsch reaction stage ( 12 ) which is a three-phase low temperature catalytic Fischer-Tropsch reaction stage, and allowing the hydrogen and carbon monoxide partially to react catalytically in the first reaction stage ( 12 ) to form hydrocarbons. At least a portion of a tail gas ( 32 ) which includes unreacted hydrogen and carbon monoxide obtained from the first reaction stage, is fed into a second Fischer-Tropsch reaction stage ( 42 ) which is a two-phase high temperature catalytic Fischer-Tropsch reaction stage. The hydrogen and carbon monoxide are allowed at least partially to react catalytically in the second reaction stage ( 42 ) to form gaseous hydrocarbons.